Findings by Carbone et al suggested that downregulation of Ets-2 in prostate cancer cells was associated with reduced levels of the anti-apoptotic protein bcl-x(L), growth regulatory factors cyclin D1, and c-myc. The gene discussed is CCND1; the disease is prostate carcinoma.